Tamim Niazi, MDCM, discusses key findings from the phase 3 DASL-HiCaP study presented at the 2026 ESMO Congress.
Tamim Niazi, MDCM
Advertisement
Tamim Niazi, MDCM, is an associate professor of oncology at McGill University and radiation oncologist at Jewish General Hospital in Montreal, Canada.
Articles by Tamim Niazi, MDCM
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ESMO 2026 Presidential Symposium II Showcases OS-Improving LBAs in Lung and GI Cancers
2
Key Takeaways From DeLLphi-305 at ESMO 2026
3
Late-Breaking Phase 3 Data Headline ESMO 2026 Presidential Symposium I
4
Olomorasib Combo Shows Manageable Liver Toxicity in KRAS G12C-Mutant NSCLC
5